Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics Inc. (DE:HTD)
FRANKFURT:HTD
Holding DE:HTD?
Track your performance easily
Corcept Therapeutics (HTD) Ownership Overview
15.02% Insiders
18.59% Mutual Funds
19.58% Other Institutional Investors
24.30% ETFs
22.51% Public Companies and
Individual Investors
The ownership structure of Corcept Therapeutics (DE:HTD) stock is a mix of institutional, retail, and individual investors. Approximately 62.48% of the company’s stock is owned by Institutional Investors, 15.02% is owned by Insiders, and 22.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 26, 2024 | xxxxxxxxxxxxx | $146626 | |
| Nov 26, 2024 | Joseph Douglas Lyon Chief Accounting & Technology Officer | xxxxxxxxxxxxx | $80032 |
| Aug 28, 2024 | xxxxxxxxxxxxx | $110737 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $56970 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $861455 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $995205 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1943760 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,766,269 | Institution | 10.28% | 552,255,768 | |
| 8,986,635 | Institution | 8.58% | 460,969,442 | |
| 7,663,951 | Institution | 7.31% | 393,122,367 | |
| 6,581,918 | Insider | 6.10% | 337,619,484 | |
| 5,512,696 | Insider | 5.30% | 282,773,741 | |
| 2,215,093 | Insider | 2.11% | 113,623,195 | |
| 1,731,930 | Institution | 1.65% | 88,839,349 | |
| 1,559,644 | Institution | 1.49% | 80,001,939 | |
| 1,286,567 | Insider | 1.23% | 65,994,454 | |
| 1,068,471 | Institution | 1.02% | 54,807,220 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,663,951 | Institution | 7.31% | 393,122,367 | |
| 1,559,644 | Institution | 1.49% | 80,001,939 | |
| 968,745 | Institution | 0.92% | 49,691,775 | |
| 904,895 | Institution | 0.86% | 46,416,589 | |
| 822,199 | Institution | 0.78% | 42,174,698 | |
| 764,261 | Institution | 0.73% | 39,202,768 | |
| 699,905 | Institution | 0.67% | 35,901,627 | |
| 657,623 | Institution | 0.63% | 33,732,772 | |
| 649,605 | Institution | 0.62% | 33,321,488 | |
| 417,648 | Institution | 0.40% | 21,423,254 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Corcept Therapeutics Inc. (DE:HTD)?
According to the latest TipRanks data, approximately 19.58% of the company's stock is held by institutional investors, 15.02% is held by insiders, and 22.51% is held by retail investors.
What percentage of Corcept Therapeutics Inc. (DE:HTD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.58% of Corcept Therapeutics Inc. (DE:HTD) stock is held by institutional investors.
What percentage of Corcept Therapeutics Inc. (DE:HTD) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.51% of Corcept Therapeutics Inc. (DE:HTD) stock is held by retail investors.
Who owns the most shares of Corcept Therapeutics Inc. (DE:HTD)?
iShares owns the most shares of Corcept Therapeutics Inc. (DE:HTD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.